Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Theralase Technologies Inc. > News Release timing
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(605)
•••
Comment by BlueFrankyon Aug 07, 2024 7:15pm
227 Views
Post# 36168561

RE:RE:News Release timing

RE:RE:News Release timingHello Eog

A question for you and others who care to join in. 

Realizing that until we actually hear what the news release is, all else is merely speculation, but indulge me for a moment, if you don't mind.

Matt's email to shareholders included a couple of eye catching sentences out of the normal, namely:

"we wanted to share some exciting news from Theralase Technologies"

and:
"Additionally, we will be providing an update on our Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study that we can’t wait to share"

My point is, words like exciting news and can't wait to share do not apply to garden variety data updates coming in from the trial and so to me, this may infer that the data would be far more compelling otherwise that email en- mass to shareholders would not have gone out and certainly not without the blessing of Roger, I can only imagine. 

So what pray tell, might be data of the "exciting - can't wait to tell" variety... And if not that then why the need for such verbiage?





 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities